Pathfinder Cell Therapy Stock (OTC: PFND)

Latest news for Pathfinder Cell Therapy (OTC:PFND) Stock

Pathfinder Cell Therapy Inc is a regenerative medicine company. It is engaged in developing novel cell-based and related therapies for the treatment of diabetes, renal diseases and medical conditions characterized by organ-specific cell damage. Further, the group has discovered a new mammalian cell type, which is able to stimulate damaged tissues to regenerate without the Pathfinder Cells (PCs) themselves being incorporated into the new tissue. Geographically the business activities are functioned through the region of United States.

PATHFINDER CELL THERAPY by Pathfinder Cell Therapy, Inc.

Comments

Pathfinder Cell Therapy

News

Latest news for Pathfinder Cell Therapy (OTC:PFND) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga